LJPC Financial Facts
General and administrative: 3.47MTotal expenses: 15.87M
See Full Income Statement
Total stockholders' (deficit) equity: 99.61M
Accrued payroll and related expenses: 795K
See Full Balance Sheet
La Jolla Pharmaceutical Company. (LJPC) Earnings
|
Expand Research on LJPC
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +0.1% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +3.0% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/15/22 | Q322 | $0.11 | $0.00 | +$0.11 | $16.06M | $12.85M | N/A |  | | Details | |
| 8/15/22 | Q222 | $0.11 | $0.00 | +$0.11 | $16.06M | $12.85M | N/A | | | Details | |
| 8/15/22 | Q222 | $0.11 | $0.00 | +$0.11 | $16.06M | $12.85M | N/A | | | Details | |
| 3/4/19 | Q418 | -$1.73 | -$1.74 | +$0.01 | $4.18M | $4.16M | N/A | | | Details | |
| 8/8/18 |  |
Q217 | -$2.02 | -$1.95 | -$0.07 | $1.59M | $2.4M | N/A | | | Details |
| 8/8/16 | Q117 | -$0.90 | -$0.99 | +$0.09 | N/A | N/A | N/A | | | Details | |
2/23/17  |
Q416 | -$1.44 | N/A | N/A | N/A | N/A | N/A | | | Details | |
| 5/6/16 | Q416 | -$0.96 | -$0.74 | -$0.22 | $234K | $210K | N/A | | | Details |
